<DOC>
	<DOCNO>NCT02293083</DOCNO>
	<brief_summary>Myofascial pain syndrome ( MPS ) common cause persistent regional pain characterize myofascial trigger point . Trigger point injection ( TPI ) use local anesthetic one effective method treatment MPS , steroid botulinum toxin add local injection . Recent study suggest hyaluronan ( HA ) could basis myofascial pain . HA within deep fascia facilitates free slide two adjacent fibrous fascial layer . If HA assume packed conformation , generally , loose connective tissue inside fascia alters density , behavior entire deep fascia underlying muscle would compromise . The investigator anticipate hyaluronidase could decrease viscosity HA near muscle fascia trigger point . Meanwhile , hyaluronidase think promote spread local anesthetic solution hydrolyze glycosidic bond within HA . Hyaluronidase show effective retro- peribulbar block ophthalmologic surgery reduce tissue edema dermatology , adhesiolysis interventional pain management . However , effect addition hyaluronidase local anesthetic TPI study . The investigator aim compare efficacy TPI addition hyaluronidase compare local anesthetic alone pain quality life MPS patient .</brief_summary>
	<brief_title>Hyaluronidase Trigger Point Injection Myofascial Pain Syndrome</brief_title>
	<detailed_description>Study approval obtain Institutional Review Board ( IRB ) Samsung medical center , write informed consent obtain participant . The required sample size determine power analysis basis previous study . The primary outcome pain intensity posterior neck upper back TPI use verbal numerical rating scale ( VNRS ) . The standard deviation VNRS assume 20 . Power calculation indicate detect 20 point difference VNRS two group ( α = 0.05 β = 0.1 ) would require sample 29 subject group . To account dropout , 33 subject recruit group . Group L receive TPI 3.2 ml 1:1 mixture 1 % lidocaine 0.9 % normal saline . Group H receive TPI volume solution supplement hyaluronidase ( H-LASE® , 1500 iu , L &amp; H Pharm. , Seoul , Korea ) 600 iu/ml . The investigator monitor vital sign sign complication bleed , hematoma , allergic reaction 30 minute . Treatment efficacy evaluate one author ( J.W.C . ) use VNRS . To reduce bias , evaluator participant inform assign group . Patients ' characteristic age , height , weight , BMI pretreatment neck disability index ( NDI ) brief pain inventory ( BPI ) analyze independent t-test . The sex distribution analyze chi-square test . P value correct Bonferroni 's method . Pretreatment VNRS duration pain evaluate Wilcoxon two-sample test . Repeated measure ANOVA use compare change VNRS time two group . Pre- post-TPI change NDI BPI compare two group Wilcoxon sign rank test independent t-test , respectively . All analysis perform SPSS 18.0 ( SPSS Inc. , Chicago , IL , USA ) statistical software . Significance assume P value less 0.05 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Adults Aged 2575 year Diagnosed myofascial pain syndrome affect trapezius muscle History allergy lidocaine hyaluronidase Anticoagulant medication antiplatelet agent within 5 day study Analgesic medication , include nonsteroidal antiinflammatory drug , tramadol , acetaminophen , opioids within 5 day study Pain related trauma within 6 month study History cervical shoulder surgery TPI within 3 month region Fibromyalgia Cervical radiculopathy myelopathy Obesity , define body mass index 27.5 high Other medical psychological condition ( cancer , rheumatoid arthritis , endocrine disease , major depression , schizophrenia )</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>